Beijing issues new policy aimed at curbing housing speculation, triggering public concernsBeijing issues new policy aimed at curbing housing speculation, triggering public concernsBeijing has abruptly unveiled a new policy setting limit on loans from the housing provident fund for buying residential property, signaling the city's heightened efforts to combat housing speculation. But the move has also raised fears especially among young people about being disqualified to apply

Why US visas are a passport to uncertainty for China’s hi-tech researchersWhy US visas are a passport to uncertainty for China’s hi-tech researchersWhen Sonia Sun returned to China in late May to renew her US visa for her postdoctoral studies in industrial engineering, she found herse…

China’s highly paid entertainers to face heavy taxes, says mediaChina’s highly paid entertainers to face heavy taxes, says mediaAfter an investigation of tax evasion launched against Fan Bingbing, China’s highest-paid actress who was at the center of a controversy…

Shanghai rolls out 'controversial' policy to attract graduates from top two Chinese universitiesShanghai rolls out 'controversial' policy to attract graduates from top two Chinese universitiesShanghai announced on Friday that it will grant fast-track Shanghai household registration authorization to graduates from Peking Univers…

China sets myopia control as new parameter for performance assessment of officialsChina sets myopia control as new parameter for performance assessment of officialsEconomic growth figure is no longer the only measurement for Chinese officials' political merits. Nowadays, they have to take students' e…

China’s second-child policy fails to reverse declining fertility ratesChina’s second-child policy fails to reverse declining fertility ratesThe People’s Daily, a mouthpiece of the Communist Party of China, recently devoted a whole page to encourage reluctant couples to have a…

China's vaccine scandal triggers overhaul of delisting rulesChina's vaccine scandal triggers overhaul of delisting rulesThe scandal of Chinese pharmaceutical maker Changchun Changsheng Biotechnology, which is found to have systematically falsified test resu…